Compounds > 1,4,7-triazacyclononane-n,n',n''-triacetic acid
Page last updated: 2024-09-03

1,4,7-triazacyclononane-n,n',n''-triacetic acid and gallium ga 68 dotatate

1,4,7-triazacyclononane-n,n',n''-triacetic acid has been researched along with gallium ga 68 dotatate in 1 studies

Compound Research Comparison

Studies
(1,4,7-triazacyclononane-n,n',n''-triacetic acid)		Trials
(1,4,7-triazacyclononane-n,n',n''-triacetic acid)		Recent Studies (post-2010)
(1,4,7-triazacyclononane-n,n',n''-triacetic acid)		Studies
(gallium ga 68 dotatate)		Trials
(gallium ga 68 dotatate)		Recent Studies (post-2010) (gallium ga 68 dotatate)
195316140314372

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bormans, G; Cleeren, F; Dekervel, J; Deroose, CM; Koole, M; Pauwels, E; Serdons, K; Tshibangu, T; Van Cutsem, E; Van Laere, K; Verslype, C1

Other Studies

1 other study(ies) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and gallium ga 68 dotatate

ArticleYear
Al
    European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:11

    Topics: Aluminum; Chelating Agents; Heterocyclic Compounds, 1-Ring; Humans; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rectal Neoplasms

2019